Government & Politics

Senate Finance Committee Democrats are seeking evidence and proposals to shape health-care legislation. Their critique of insurers has merit, but reforms confined to insurance risk leaving hospitals, conglomerates, and much of the system’s extraction untouched, sets the stage for further disappointment.

Senate Finance Committee Democrats have invited outside evidence and proposals for their next health-care agenda. Their critique of insurers has force, but the remedies leave most of the system untouched, risking further disappointment unless reform reaches hospitals and entire conglomerates.

Social Security runs on the paycheck. But a growing share of American wealth now comes from profits, assets, and ownership. The program that ended old-age poverty was never built for an economy that pays people this way.

The upheaval in Maine’s Senate race has focused attention on candidates and party leaders. Less noticed is what the campaign finance data reveal about the state’s Democratic Party and its structural dependence on national organizations and large out-of-state donors.

What can one Senate race reveal about the hidden machinery of American politics? In Maine, donor patterns expose how campaign finance can shape party competition, political narratives, and the choices voters are asked to make long before ballots are counted.

We’ve inherited a stubborn reflex for resisting fatcats, oligarchs, profiteers, and anyone who tries to run roughshod over us.

SOAS Anti-Corruption Evidence and the Institute for New Economic Thinking are convening a two-day conference for UK-based early career researchers working on governance, corruption, and related political economy issues in the Global South.

The Institute for New Economic Thinking (INET) and the Cambridge Central Asia Forum, University of Cambridge, in partnership with The Green Industrial Policy in the Age of Rare Metals: A Transregional Comparison of Growth Strategies in Rare Earth Mining Project (Funded by European Research Council (ERC) administered by University of Sussex, UK., are organizing the Research in Action Workshop 2026: The Science of Critical Minerals and the Realigning Global Order, on 27–28 April 2026 at the University of Cambridge.

Equality runs deeper than preference or policy fashion, rooted in human social instincts and reflected in outcomes across societies. It is time for economics and policy alike to reckon with how profoundly distribution shapes well-being and social stability.

The struggle over the Federal Reserve is not just a dispute about central bank independence. It is a constitutional conflict over democratic sovereignty itself: in a representative system, the power to make money belongs first to the legislature, not the executive.

Affordable medicines remain out of reach for millions because pharmaceutical innovation is organized around value extraction, not public health. How do shareholder-driven governance and fragmented global health financing reinforce inequity, and what structural reforms are needed to reverse it?

As the Supreme Court’s unitary executive theory reaches the Federal Reserve, a deeper constitutional question comes into view: who holds the power to make money?

The global medicine-access crisis is not simply a failure to balance innovation and affordability. It reflects a deeper system in which shareholder-driven pharmaceutical governance and fragmented donor structures undermine public health and block the shift toward more equitable value creation.

A case for tackling the corporate machinery driving extreme wealth, and the reforms that could truly curb it.

Authors Bill Bergman and Larry Feltes argue that declining public confidence in government and financial institutions is putting the U.S. economy in peril — and a crisis could come faster than you think.